$0.860000
0.033.12%
At Close: -
$0.899300
0.044.57%
After Hours: Jul 24, 6:51 PM EDT
15 minutes delayed
ImmunoPrecise Antibodies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ImmunoPrecise Antibodies using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
IPA | ImmunoPrecise Antibodies | -$0.04 | — | — | — | $4.26M | — | — | — | 09/12/2024 | Get Alert |
IPA | ImmunoPrecise Antibodies | -$0.15 | -$0.08 | — | — | $4.15M | $4.78M | — | — | 07/29/2024 | Get Alert |
IPA | ImmunoPrecise Antibodies | -$0.14 | -$0.07 | -$0.08 | -14.29% | $3.84M | $4.50M | $4.55M | 1.22% | 03/14/2024 | Get Alert |
IPA | ImmunoPrecise Antibodies | -$0.23 | -$0.10 | -$0.07 | 26.00% | $3.90M | $4.33M | $4.62M | 6.74% | 12/14/2023 | Get Alert |
IPA | ImmunoPrecise Antibodies | -$0.30 | -$0.15 | -$0.10 | 33.33% | $3.65M | $3.94M | $4.26M | 8.17% | 09/14/2023 | Get Alert |
IPA | ImmunoPrecise Antibodies | $0.17 | -$0.13 | -$0.15 | -15.38% | $4.11M | $4.23M | $4.15M | -1.87% | 07/07/2023 | Get Alert |
IPA | ImmunoPrecise Antibodies | -$0.16 | -$0.17 | -$0.14 | 17.65% | $3.80M | $3.96M | $3.84M | -3.11% | 03/16/2023 | Get Alert |
IPA | ImmunoPrecise Antibodies | -$0.21 | — | -$0.23 | — | $3.76M | $3.84M | $3.90M | 1.51% | 12/15/2022 | Get Alert |
IPA | ImmunoPrecise Antibodies | -$0.14 | — | -$0.30 | — | $3.73M | $4.02M | $3.65M | -9.33% | 09/14/2022 | Get Alert |
IPA | ImmunoPrecise Antibodies | -$0.29 | — | $0.17 | — | $4.88M | $4.48M | $4.11M | -8.37% | 07/29/2022 | Get Alert |
IPA | ImmunoPrecise Antibodies | — | -$0.13 | -$0.16 | -23.08% | — | $4.14M | $3.80M | -8.16% | 03/16/2022 | Get Alert |
IPA | ImmunoPrecise Antibodies | — | — | -$0.21 | — | — | — | $3.76M | — | 12/13/2021 | Get Alert |
IPA | ImmunoPrecise Antibodies | — | — | -$0.14 | — | — | — | $3.73M | — | 09/09/2021 | Get Alert |
IPA | ImmunoPrecise Antibodies | -$0.01 | — | -$0.29 | — | $4.15M | — | $4.88M | — | 07/28/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-03-14 | $-0.08 | $-0.07 | -14.3 % |
Sep 2023 | 2023-12-14 | $-0.07 | $-0.10 | 26.0 % |
Jun 2023 | 2023-09-14 | $-0.10 | $-0.15 | 33.3 % |
Jun 2023 | 2023-07-07 | $-0.15 | $-0.13 | -15.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-03-14 | $4.56M | $4.50M | 1.22 % |
Sep 2023 | 2023-12-14 | $4.62M | $4.33M | 6.74 % |
Jun 2023 | 2023-09-14 | $4.26M | $3.94M | 8.17 % |
Jun 2023 | 2023-07-07 | $4.15M | $4.23M | -1.87 % |
ImmunoPrecise Antibodies (IPA) is scheduled to report earnings on September 12, 2024. The last reported earnings were for reported on March 14, 2024 for Q3.
The Actual EPS was $-0.08, which missed the estimate of $-0.07.
The Actual Revenue was $4.6M, which beat the estimate of $4.5M.
Browse earnings estimates, EPS, and revenue on all stocks.